27 results
8-K
EX-99.1
TSBX
Turnstone Biologics Corp
13 May 24
Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights
5:03pm
TIDAL-01 clinical trials offset by a decrease of $0.9 million in clinical and regulatory costs and $1.6 million in pre-clinical research and development … Ended March 31,
Collaboration revenue
Operating expenses:
Research and development
General and administrative
Total operating expenses
Loss from
DEF 14A
TSBX
Turnstone Biologics Corp
22 Apr 24
Definitive proxy
4:28pm
Medical Officer since March 2022. Prior to this, Dr. Burgess served as our President of Research and Development from October 2017 to May 2021. Dr. Burgess … has also served on the board of directors of Synlogic, Inc. (Nasdaq: SYBX) since 2021. Dr. Burgess has served as the Head of Research and Development
10-K
2023 FY
TSBX
Turnstone Biologics Corp
21 Mar 24
Annual report
8:51pm
manufacturing and conduct preclinical studies of any of our product candidates;
the success, cost and timing of our research and development activities … , Ph.D., who brings over 20 years of research and development experience in cell-based and immune-oncology products from Adicet, Fate, Celgene and GE
8-K
EX-99.1
TSBX
Turnstone Biologics Corp
21 Mar 24
Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business Highlights
5:14pm
, cash equivalents and short-term investments will be sufficient to fund its operations into the second quarter of 2025.
Research and Development (R&D … December 31,
Twelve Months ended December 31,
Collaboration revenue
Operating expenses
Research and development
General and administrative
Total
8-K
EX-99.1
9ixfe
5 Mar 24
Regulation FD Disclosure
8:30am
10-Q
syq49q3xp6u3lum145s
1 Sep 23
Quarterly report
4:39pm
424B4
ol6cd z4pcghdstq
21 Jul 23
Prospectus supplement with pricing info
7:14pm
CORRESP
868y9
5 Jul 23
Correspondence with SEC
12:00am
S-1/A
yfo4cacc6jsid
23 Jun 23
IPO registration (amended)
9:49pm
CORRESP
pkd8u 78f
23 Jun 23
Correspondence with SEC
12:00am
UPLOAD
27pvl9sjmyaggbn0n
22 Jun 23
Letter from SEC
12:00am
CORRESP
05esaq sq
21 Jun 23
Correspondence with SEC
12:00am
S-1
EX-10.9
obvihon8
12 Jun 23
IPO registration
4:28pm
S-1
EX-2.1
v07w0by6 q8
12 Jun 23
IPO registration
4:28pm
S-1
hxi3yoh6l 3qz3
12 Jun 23
IPO registration
4:28pm
S-1
EX-10.15
qfm4dodgpzq8
12 Jun 23
IPO registration
4:28pm
S-1
EX-10.8
0d10d6fg2p8ulv 1l0s
12 Jun 23
IPO registration
4:28pm